同源性人类iPSC帕金森病模型显示MEF2-PGC1α转录中的化应激诱导功能障碍
Scott D Ryan1, Nima Dolatabadi, Shing Fai Chan
1Del E. Web Center for Neuroscience, Aging, and Stem Cell Research, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Cell
|December 3, 2013
概括
帕金森病涉及多巴胺基神经元损失. 线粒体毒素引发氧化应激,S-化MEF2C,抑制MEF2C-PGC1α网络,并导致细胞死亡,揭示了治疗点.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 毒理学 毒理学 毒理学
背景情况:
- 帕金森病 (PD) 与黑色物质紧体 (SNpc) 中多巴胺基 (DA) 神经元的损失有关.
- 环境中的线粒体毒素,如paraquat,maneb和rotenone,与PD有关.
- 一个患者衍生干细胞模型允许研究A53Tα-synuclein (α-syn) 突变DA神经元 (hNs) 与同源对照相比.
研究的目的:
- 为了研究A53Tα-syn突变DA神经元中线粒体毒素诱导的细胞干扰.
- 阐明在PD病变发生过程中基因与环境相互作用背后的分子机制.
- 在已识别的分子通路内识别潜在的治疗点.
主要方法:
- 使用患者衍生干细胞模型的PD与A53Tα-syn突变和同位素突变纠正的DA神经元.
- 分析了化/氧化应激标志物和转录因子MEF2C的S-化.
- 评估了对MEF2C-PGC1α转录网络和线粒体功能的影响.
- 进行小分子高通量查以确定治疗点.
主要成果:
- 线粒体毒素在A53Tα-syn突变DA神经元中诱导了化/氧化应激.
- 暴露于毒素导致MEF2C的S-化,抑制了MEF2C-PGC1α转录网络.
- 这种抑制导致线粒体功能障碍和细胞死亡.
- 确定了MEF2C-PGC1α通路作为PD病变发生的关键参与者.
结论:
- 基因与环境的相互作用,特别是毒素诱导的MEF2C S-化,有助于PD的发病.
- MEF2C-PGC1α通路是PD治疗干预的关键目标.
- 针对这种途径的小分子对抗PD具有前途.
相关概念视频
Parkinson Disease ll: Pathophysiology
34
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
34
EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K


